Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | D3S-002 |
Trade Name | |
Synonyms | D3S 002|D3S002 |
Drug Descriptions |
D3S-002 selectively inhibits Erk1 and Erk2, potentially leading to decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 5501). |
DrugClasses | ERK Inhibitor (pan) 21 |
CAS Registry Number | NA |
NCIT ID | C200823 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
D3S-001 + D3S-002 | D3S-001 D3S-002 | 0 | 0 |
D3S-002 | D3S-002 | 0 | 1 |